Cargando…
Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis
Epigenetic mechanisms such as histone modification play key roles in the pathogenesis of multiple myeloma (MM). We previously showed that EZH2, a histone H3 lysine 27 (H3K27) methyltransferase, and G9, a H3K9 methyltransferase, are potential therapeutic targets in MM. Moreover, recent studies sugges...
Autores principales: | Ishiguro, Kazuya, Kitajima, Hiroshi, Niinuma, Takeshi, Maruyama, Reo, Nishiyama, Naotaka, Ohtani, Hitoshi, Sudo, Gota, Toyota, Mutsumi, Sasaki, Hajime, Yamamoto, Eiichiro, Kai, Masahiro, Nakase, Hiroshi, Suzuki, Hiromu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803977/ https://www.ncbi.nlm.nih.gov/pubmed/33436557 http://dx.doi.org/10.1038/s41420-020-00400-0 |
Ejemplares similares
-
DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
por: Ishiguro, Kazuya, et al.
Publicado: (2019) -
UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019) -
TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells
por: Kai, Masahiro, et al.
Publicado: (2016) -
TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells
por: Kitajima, Hiroshi, et al.
Publicado: (2023) -
DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes
por: Hatanaka, Yui, et al.
Publicado: (2021)